Caira Surgical

Executive Summary

Caira Surgical is a private medical device company developing a novel radar-based computer navigation system for joint replacement surgery, with an initial focus on total knee arthroplasty. Founded by surgeons in 2015 and headquartered in San Jose, California, the company aims to address limitations of existing navigation technologies by offering a proprietary tracking platform that enhances precision, simplifies workflow, and improves accessibility for orthopedic surgeons. Unlike conventional optical or electromagnetic systems, Caira's radar-based approach is designed to be less intrusive, more robust to line-of-sight issues, and potentially more cost-effective, which could drive adoption in outpatient and community hospital settings. The company's technology is still in development, and it has not yet disclosed funding or regulatory milestones. However, the strong clinical need for better alignment and implant positioning in knee replacement, combined with the growing trend toward computer-assisted surgery, positions Caira to capture market share if its system demonstrates superior accuracy and ease of use. Key risks include navigating FDA 510(k) clearance, competing with established players (e.g., Stryker, Zimmer Biomet), and proving clinical utility in real-world settings.

Upcoming Catalysts (preview)

• Q1 2027Initial 510(k) submission for knee navigation system60% success
• Q3 2026Publication of pilot clinical study results70% success
• Q4 2026Strategic partnership or distribution agreement50% success